Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Centro de investigaciones y Publicaciones Farmacéuticas
2019
|
| Subjects: | |
| Online Access: | https://www.redalyc.org/articulo.oa?id=69060019004 https://www.redalyc.org/journal/690/69060019004/ https://www.redalyc.org/journal/690/69060019004/html/ https://www.redalyc.org/journal/690/69060019004/69060019004.epub https://www.redalyc.org/journal/690/69060019004/movil |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Clinical pharmacist implementation of a medication assessment tool for long-term management of atrial fibrillation in older persons Marise Gauci Francesca Wirth Lilian M. Azzopardi Anthony Serracino-Inglott Medicina Aged Malta Pharmacists Clinical Audit Disease Management Background: Optimisation of drug therapy is important in the older population and may be facilitated by medication assessment tools (MATs).Objective: The purpose of the study was to evaluate whether appropriateness of drug therapy and clinical pharmacist intervention documentation improved following implementation of a previously developed MAT for the long-term management of atrial fibrillation (MAT-AF).Methods: Adherence to MAT-AF review criteria and clinical pharmacist intervention documentation was assessed by the researcher pre-MAT implementation in 150 patients aged ≥60 years admitted to a rehabilitation hospital with a diagnosis of atrial fibrillation. MAT-AF was introduced as a clinical tool in the hospital for identification of pharmaceutical care issues in atrial fibrillation patients. Adherence to MAT-AF and pharmacist intervention documentation were assessed by the researcher post-MAT implementation for a further 150 patients with the same inclusion criteria. Logistic regression analysis and measurement of odds ratio was used to identify differences in adherence to MAT-AF pre- and post-MAT implementation. The differences between two population proportions z-test was used to compare pharmacist intervention documentation pre- and post-MAT implementation.Results: Adherence to MAT-AF criteria increased from 70.9% pre-implementation to 89.6% post-implementation. MAT-AF implementation resulted in a significant improvement in prescription of anticoagulant therapy (OR 4.07, p<0.001) and monitoring of laboratory parameters for digoxin (OR 10.40, p<0.001). Clinical pharmacist intervention documentation improved significantly post-implementation of MAT-AF (z-score 20.249, p<0.001).Conclusions: Implementation of MAT-AF within an interdisciplinary health care team significantly improved the appropriateness of drug therapy and pharmacist intervention documentation in older patients with atrial fibrillation. 2019 artículo científico 1885-642X https://www.redalyc.org/articulo.oa?id=69060019004 https://www.redalyc.org/journal/690/69060019004/ https://www.redalyc.org/journal/690/69060019004/html/ https://www.redalyc.org/journal/690/69060019004/69060019004.epub https://www.redalyc.org/journal/690/69060019004/movil 10.18549/PharmPract.2019.1.1349 en http://www.redalyc.org/revista.oa?id=690 Pharmacy Practice application/pdf Centro de investigaciones y Publicaciones Farmacéuticas Pharmacy Practice (España) Num.1 Vol.17